Naslund Medical manufactures and markets Gold Anchor™, a soft tissue gold marker for increased accuracy and precision in radiotherapy. Through the industry leading small needle size and unique marker design Gold Anchor™ offers superior reach to any inner organ and more reliable localization over time.
Vision Zero Cancer is a Swedish innovation milieu that engages actors across society in strategic actions to work jointly in the mission of beating cancer. The founders are the Confederation of Regional Cancer Centres at the Swedish Association of Local Authorities and Regions, Stockholm School of Economics, AstraZeneca and Elekta. It is managed as a partnership, led by an office at House of Innovation, Stockholm School of Economics.